MetLife, Inc.
CorpDigest
MetLife, Inc.
Financial Performance
Last reviewed: June 2025 · By Swet Parvadiya
Revenue
$69.8B
Market Cap
$62.0B
Net Income
$6.5B
Employees
45,000
Revenue has been remarkably stable: $69.64 billion in FY2021, $69.6 billion in FY2022, $68.4 billion in FY2023, and $69.8 billion in FY2024. That flatness reflects the maturity of the group benefits market and the steady nature of insurance premium collection. Net income of $6.5 billion in FY2024 represents a 9.3% net margin — consistent with the economics of a large insurance carrier where investment spread and underwriting margin both contribute to profitability. Market capitalization of $62 billion against $69.8 billion in revenue implies a slight discount to book value, typical for insurance companies where the market applies caution about long-tail liability reserves and interest rate sensitivity in the investment portfolio. The Brighthouse spin-off removed the variable annuity liabilities that most directly create interest rate and equity market exposure; what remains is a cleaner risk profile centered on group benefits and international life insurance. MetLife Investment Management deploys premium float across global credit markets, generating investment income that supplements underwriting margin. The scale of assets under management — hundreds of billions across multiple asset classes — creates economies of research and execution that smaller insurance companies cannot match, which translates into incremental yield advantage that compounds across the investment portfolio. The 2004 Eliot Spitzer bid-rigging investigation, the 2012 systemic risk designation battle, and the 2014 variable annuity capital charge dispute each represented significant financial and regulatory risks that the company navigated. The Brighthouse spin-off in 2017 directly addressed the variable annuity capital issue by moving those liabilities into a separate company, demonstrating that MetLife's management has been willing to take structural action to address financial risks rather than manage them in place.
Revenue Trend Analysis
YoY Change
+2%
3-Year CAGR
+0.1%
Peak Year
2024
Trend
Declining Trend
MetLife, Inc. has reported revenue across 4 fiscal years, compounding at +0.1% annually over 3 years. The most recent year saw a 2% increase versus the prior year. Revenue peaked in 2024 at $69.8B. Out of 3 reported periods, 1 showed growth and 2 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $69.8B | $6.5B | +2.0% |
| FY2023 | $68.4B | — | -1.7% |
| FY2022 | $69.6B | — | -0.1% |
| FY2021 | $69.6B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
MetLife's revenue has remained remarkably flat across four consecutive fiscal years: $69.64 billion in FY2021, $69.6 billion in FY2022, $68.4 billion in FY2023, and $69.8 billion in FY2024. This flatness is not a sign of stagnation — it is a structural characteristic of a mature, large-scale insurance enterprise with highly predictable premium collection. Life insurance and group benefits premiums do not fluctuate dramatically with economic cycles the way technology or consumer discretionary revenues do. Employers renew group insurance contracts annually with modest premium increases reflecting benefit cost inflation and headcount changes. Net investment income, the second major revenue component, fluctuates with interest rates and portfolio composition but within a manageable band. The key insight from this stability is cash flow predictability: MetLife can forecast premium inflows with actuarial precision, enabling disciplined capital allocation — the company has consistently returned $3+ billion annually to shareholders through dividends and buybacks while simultaneously investing in digital infrastructure. Revenue stability also signals the absence of large transformative acquisitions in this period, consistent with MetLife's post-Brighthouse focus on organic growth and capital efficiency rather than acquisitive expansion. The FY2024 recovery to $69.8 billion from the FY2023 trough of $68.4 billion reflects favorable interest rate tailwinds on net investment income as the Federal Reserve's rate hike cycle improved yields on the investment portfolio, demonstrating that MetLife's revenues do respond positively to higher rates over a multi-year horizon.
MetLife's market capitalization of approximately $62 billion against annual revenue of $69.8 billion implies a price-to-revenue ratio of less than 1x — a valuation that would appear extreme in technology or consumer sectors but is normal for large insurance companies. The apparent discount reflects the unique economics of insurance: revenue includes gross premiums, which are substantially offset by policyholder benefits, claims, and reserves before generating profit. Net income of approximately $6.5 billion in FY2024 implies a net margin of roughly 9.3%, and on a price-to-earnings basis MetLife trades at approximately 10x trailing earnings — consistent with the peer group of large US life insurers. The market applies a discount to insurance earnings for several structural reasons: long-tail liability uncertainty (insurance reserves involve actuarial estimates that can prove incorrect years later), interest rate sensitivity (the investment portfolio is long-duration and mark-to-market values fluctuate with rate changes), and regulatory capital constraints that limit the speed of capital return to shareholders. MetLife's market cap relative to book value — typically 1x to 1.3x for large US life insurers — reflects these constraints alongside the company's demonstrated ability to generate consistent return on equity. The Brighthouse spin-off improved MetLife's return on equity profile by removing capital-heavy variable annuity liabilities, and this structural improvement has been partially recognized in relative valuation, though the sector as a whole trades at discounts to other financial industries.
MetLife has maintained a consistent and substantial capital return program in the years following the Brighthouse Financial spin-off in 2017. The company typically returns $3–4 billion annually to shareholders through a combination of share repurchases and quarterly dividends. The dividend has been increased consistently, reflecting management confidence in the durability of earnings. Share repurchases systematically reduce the outstanding share count, accreting earnings per share even without top-line revenue growth — a dynamic that has driven meaningful EPS growth over the period. The capacity for this capital return program rests on two foundations: the free cash flow generative nature of the group benefits segment (which converts premium revenue into distributable capital efficiently) and the fortress-like statutory capital position MetLife maintains, which significantly exceeds regulatory minimums set by the National Association of Insurance Commissioners. The statutory capital buffer — capital held above regulatory requirements — provides the flexibility to sustain returns through adverse cycles. MetLife demonstrated this resilience during the COVID-19 period in 2020 when elevated mortality claims increased policyholder payouts, but the company maintained its dividend and repurchase activity without accessing external capital markets. The capital return program functions as a signal of management's conviction that the business model produces genuine excess returns above the capital required to maintain its insurance obligations — a message reinforced by the consistent execution across varying interest rate and economic environments.
Interest rates are the single most important macroeconomic variable for MetLife's financial performance, operating through multiple channels simultaneously. Higher rates improve net investment income as maturing bonds are reinvested at higher yields, expanding the spread between portfolio return and policyholder crediting rates. The Federal Reserve's aggressive rate hiking cycle beginning in early 2022 — taking the federal funds rate from near zero to over 5% by mid-2023 — created a meaningful tailwind for MetLife's investment portfolio over the subsequent reinvestment cycle. As the company's fixed-income portfolio, which carries an average duration of roughly 8–10 years, gradually turns over, new purchases capture higher yields. This contributed to the FY2024 revenue recovery to $69.8 billion from FY2023's $68.4 billion. However, higher rates also create headwinds: the mark-to-market value of existing fixed-income securities declines as rates rise, creating unrealized losses in other comprehensive income that reduce book value per share, though these losses do not affect statutory capital or operating earnings under insurance accounting. Higher rates also increase the cost of any floating-rate debt MetLife carries. For the variable annuity business that was spun off as Brighthouse, rate sensitivity was even more acute due to embedded guarantees. MetLife's post-Brighthouse focus on group benefits and international products with shorter liability durations has reduced its overall interest rate sensitivity, a deliberate structural improvement that management has highlighted as a benefit of the 2017 spin-off strategy.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "MetLife, Inc. Revenue & Financials." CorpDigest, https://corpdigest.com/company/metlife/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>MetLife, Inc. reported $70B in revenue (FY2024).</strong><br>Source: <a href="https://corpdigest.com/company/metlife/financials" target="_blank" rel="noopener">CorpDigest — MetLife, Inc. financials</a></div>